Terms: = Thyroid cancer AND TOP2A, TOP2, TP2A AND Treatment
7 results:
1. Bioinformatics analysis to identify breast cancer-related potential targets and candidate small molecule drugs.
Hong H; Chen H; Zhao J; Qin L; Li H; Huo H; Shi S
Mutat Res; 2023; 827():111830. PubMed ID: 37437506
[TBL] [Abstract] [Full Text] [Related]
2. Integration of transcriptomics and metabolomics reveals anlotinib-induced cytotoxicity in colon cancer cells.
Jia Z; Zhang Z; Tian Q; Wu H; Xie Y; Li A; Zhang H; Yang Z; Zhang X
Gene; 2021 Jun; 786():145625. PubMed ID: 33798683
[TBL] [Abstract] [Full Text] [Related]
3. A novel RNA sequencing-based risk score model to predict papillary thyroid carcinoma recurrence.
He J; Tian Z; Yao X; Yao B; Liu Y; Yang J
Clin Exp Metastasis; 2020 Apr; 37(2):257-267. PubMed ID: 31792675
[TBL] [Abstract] [Full Text] [Related]
4. Broken by the Cut: A Journey into the Role of Topoisomerase II in DNA Fragility.
Atkin ND; Raimer HM; Wang YH
Genes (Basel); 2019 Oct; 10(10):. PubMed ID: 31614754
[TBL] [Abstract] [Full Text] [Related]
5. Integrated Bioinformatics Analysis of Master Regulators in Anaplastic thyroid Carcinoma.
Pan Z; Li L; Fang Q; Qian Y; Zhang Y; Zhu J; Ge M; Huang P
Biomed Res Int; 2019; 2019():9734576. PubMed ID: 31183379
[TBL] [Abstract] [Full Text] [Related]
6. Regulation of MMP13 by antitumor microRNA-375 markedly inhibits cancer cell migration and invasion in esophageal squamous cell carcinoma.
Osako Y; Seki N; Kita Y; Yonemori K; Koshizuka K; Kurozumi A; Omoto I; Sasaki K; Uchikado Y; Kurahara H; Maemura K; Natsugoe S
Int J Oncol; 2016 Dec; 49(6):2255-2264. PubMed ID: 27779648
[TBL] [Abstract] [Full Text] [Related]
7. Associations between clinical characteristics and oncogene expression in patients with non-small cell lung cancer.
Han Y; Yu DP; Zhou SJ; Song XY; Li YS; Xiao N; Liu ZD; Sun XJ; Zhao QY; Liu SK
Genet Mol Res; 2014 Oct; 13(4):8913-24. PubMed ID: 25366782
[TBL] [Abstract] [Full Text] [Related]
